23 янв. 2020 г. · NICE has accredited the process used by the BSR to produce its guideline on the diagnosis and treatment of giant cell arteritis. Introduction · Rigour of development · General principles

23 янв. 2020 г. · 1. Strong recommendation: Patients with suspected GCA should have a confirmatory diagnostic test. This could be either a temporal artery biopsy ...

23 янв. 2020 г. · Our updated guideline on its treatment ensures clinicians have the latest information about diagnosis and treatment, bringing the latest peer-reviewed evidence ...

Clearly defined referral pathways and well-coordinated teams ensure that care is patient-centred.

1 мар. 2020 г. · British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis.

BSR's 'gold standard' clinical guidelines support evidence-based clinical practice in rheumatology. Our guidelines are developed using the methods and ...

1 авг. 2024 г. · ACR/VF and BSR guidelines recommend against the use of statins for the treatment of GCA. Once the disease is in remission, EULAR guidelines ...

22 окт. 2024 г. · Rheumatology (BSR) guideline [5]. Objectives: To provide guidance for clinicians in the. diagnosis and treatment of GCA, supported by evidence.

16 июл. 2020 г. · The major change in this guidance is now a strong recommendation for a confirmatory test: TAB, temporal artery ultrasound, or both.

BSR and BHPR guidelines for the management of giant cell arteritis. Rheumatology (Oxford). 2010 Aug;49(8):1594-7.